, Volume 2, Issue 4, pp 321-329


Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Opinion statement

The only definitive therapy for patients with pheochromocytoma is surgical resection [1,2]. Advances in preoperative medical management of hypertension/hypovolemia and improved intraoperative anesthetic care have reduced the operative mortality rate for pheochromocytoma to less than 5% in most series [3]. In addition, accurate preoperative localization studies have eliminated the need for extensive exploratory laparotomy. Focused approach and laparoscopic resection have become the new “gold standard,” with a reduced morbidity [4]. Large or locally invasive pheochromocytomas may still require open resection.